Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication. "We at Zealand Pharma are acutely aware of the significant unmet medical need for newborns and children with ...

This raises your blood sugar level. Baqsimi is a nasal spray. It’s given as one spray into one nostril during an episode of severe hypoglycemia. With severe hypoglycemia, your blood sugar level ...

The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...

STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...

Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...